Clinical Trial Update: Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of Farxiga on renal function and kidney size in adults with type 2 diabetes and hyperfiltration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2023-11-30